We are monitoring the impact of COVID-19 on APAC HIV Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2055
Share on
Share on

Asia Pacific HIV Diagnostics Market Research Report - Segmented By Product, By Type, By End User & By Country() - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: February, 2020
ID: 2055
Pages: 130

APAC HIV diagnostics Market Size & Growth (2019 – 2024)

As per the research report, the size of the Asia Pacific HIV Diagnostics Market is valued at USD 680 million in 2019 and is estimated to be growing at a growth rate of 10.40%, to reach 1110 million by 2024 during the forecast period 2019-2024.

The human immunodeficiency virus (HIV) can be described as a kind of retrovirus that causes (AIDS). HIV affects the immune cells and thus weakens immune system bringing about loss of ability to fight against the organisms that cause diseases.

HIV infection has no cure however there are medicines which help to balance out or decrease this infection so it doesn't prompt to AIDS. HIV diagnostics market is developing at a significant rate because of increment in the HIV infected cases and developing awareness about the same.  The current situation is like various POC/rapid tests are in clinical examination and advancement in the item pipelines of significant market members and therefore are relied upon to acquire regulatory approval in different local segments of the market. This general increment in the quantity of item offerings to the market space around the world, is required to drive the development of the HIV diagnostics industry in the forecast period.

Major factors driving the market are, and the foreseen improvement and commercialization of novel, the technological advancement in disease diagnostic tests, regulatory authorities approved POC as well as rapid CD4, p24 antigen and EID tests; it is expected of all the major regional market segments to witness a growth in the market demand over the given period. There is a need to increase in introducing easily accessible, efficient robust diagnostics tests. Because of the financial resource constrained settings in a huge share of the disease affected regions it is as yet not feasible to perform the current, complex screening, staging and monitoring tests. This is either because of the absence of adequate testing labs or an absence of prepared clinical technicians capable of performing the tests. These limitations of laboratory based testing are a catalyst to the improvement of convenient and simple to execute point of care, rapid tests.

This research report segmented and sub-segmented into the following categories:

  • By Product: Consumables, Instruments, Software & Services                
  • By Type: Antibody Tests, Viral Identification Tests, CD4 Testing, Viral Load testing, Early Infant Diagnostics              
  • By End User: Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, Other End Users             
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

North America was followed by Asia pacific in terms of revenue. Asia Pacific is predicted to grow at a rapid pace in the coming few years, because of its high unmet demand in India and China.

The Top companies leading in the APAC HIV diagnostics Market profiled in the report are Abbott Healthcare, Brsitol-Myers Squibb, Alere Inc., Abbvie Inc., Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, VIIV Healthcare, BD Biosciences, Beckman Coulter, Partec, Sysmex, Zyomyx Inc., Apogee Flow Systems, Mylan inc., PointCare Roche Diagnostics, Technologies Inc., Qiagen, Siemens Healthcare, and bioMerieux dominated HIV diagnostics market share in 2016.

1.Introduction          

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Product

                                5.1.1 Introduction                                           

                                5.1.2 Consumables                                         

                                                5.1.2.1 Assays and Kits &Reagents                           

                                                5.1.2.2 Other Consumables                        

                                5.1.3 Instruments                                           

                                5.1.4 Software & Services                                            

                                5.1.5  Y-o-Y Growth Analysis, By Product                                              

                                5.1.6  Market Attractiveness Analysis, By Product                                            

                                5.1.7  Market Share Analysis, By Product                                              

                5.2 Type      

                                5.2.1 Introduction                                           

                                5.2.2 Antibody Tests                                      

                                                5.2.2.1 HIV Screening Tests                         

        5.2.2.1.1 Elisa    

        5.2.2.1.2 Rapid Tests      

        5.2.2.1.3 Home Access Dried Blood Spots             

                                                5.2.2.2 HIV-1 Antibody Confirmatory Tests                          

        5.2.2.2.1 Western Blot Tests       

        5.2.2.2.2  Indirect Immunofluorescence Assays (IFA)      

        5.2.2.2.3 Line Immunoassays     

        5.2.2.2.4 Radio-Immunoprecipitation Assays      

                                                5.2.2.3  HIV-2 & Group O Diagnostic Tests                            

        5.2.2.3.1 Blood Antibody Tests  

        5.2.2.3.2 DBS Tests         

        5.2.2.3.3 Line ImmunoAssay (HIV2)         

                                5.2.3 Viral Identification Tests                                    

                                                5.2.3.1 p24 Antigen Test                               

                                                5.2.3.2 Qualitative PCR Tests                      

                                                5.2.3.3 Viral Culture                        

                                5.2.4 CD4 Testing                                             

                                5.2.5 Viral Load testing                                  

                                5.2.6 Early Infant Diagnostics                                      

                                5.2.7 Y-o-Y Growth Analysis, By Type                                     

                                5.2.8 Market Attractiveness Analysis, By Type                                   

                                5.2.9 Market Share Analysis, By Type                                     

                5.3 End User      

                                5.3.1 Introduction                                           

                                5.3.2 Diagnostic Laboratories                                     

                                5.3.3 Hospitals                                  

                                5.3.4 Blood Banks                                            

                                5.3.5 Home Care Settings                                            

                                5.3.6 Other End Users                                   

                                5.3.7 Y-o-Y Growth Analysis, By End User                                             

                                5.3.8  Market Attractiveness Analysis, By End User                                          

                                5.3.9  Market Share Analysis, By End User                                            

6. Geographical Analysis                      

                6.1 Introduction       

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Product                           

                                                6.1.3.3 By Type                 

                                                6.1.3.4 By End User                        

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Product                           

                                                6.1.4.3 By Type                 

                                                6.1.4.4 By End User                        

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Product                           

                                                6.1.5.3 By Type                 

                                                6.1.5.4 By End User                        

                6.2 China     

                6.3 India      

                6.4 Japan    

                6.5 South Korea       

                6.6 Australia      

7.Strategic Analysis                

                7.1 PESTLE analysis 

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis      

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                 

                8.1 Siemens Healthineers (A Division of Siemens AG)     

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Roche Diagnostics (Division of Hoffman La Roche Ltd.)    

                8.3 Abbott Laboratories       

                8.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)  

                8.5 Thermo-Fisher Scientific Inc.       

                8.6 Merck KGaA       

                8.7 Becton, Dickinson & Company   

                8.8 Hologic Inc.

                8.9 Alere Inc.     

                8.10 Bio-Rad Laboratories    

9.Competitive Landscape                    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities                  

Appendix                   

                a) List of Tables

                b) List of Figures      

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific HIV Diagnostics Market By Product, From 2019-2024 ( USD Million )
  2. Asia-Pacific Consumables Market By Region, From 2019-2024 ( USD Million )
  3. Asia-Pacific Instruments Market By Region, From 2019-2024 ( USD Million )
  4. Asia-Pacific Software & Services Market By Region, From 2019-2024 ( USD Million )
  5. Asia-Pacific HIV Diagnostics Market By Type, From 2019-2024 ( USD Million )
  6. Asia-Pacific Antibody Tests Market By Region, From 2019-2024 ( USD Million )
  7. Asia-Pacific Viral Identification tests Market By Region, From 2019-2024 ( USD Million )
  8. Asia-Pacific CD4 Testing Market By Region, From 2019-2024 ( USD Million )
  9. Asia-Pacific Viral Load Testing Market By Region, From 2019-2024 ( USD Million )
  10. Asia-Pacific Early Infant Diagnosticss Market By Region, From 2019-2024 ( USD Million )
  11. Asia-Pacific HIV Diagnostics Market By End-User, From 2019-2024 ( USD Million )
  12. Asia-Pacific Diagnostic Labortaries Market By Region, From 2019-2024 ( USD Million )
  13. Asia-Pacific Hospitals Market By Region, From 2019-2024 ( USD Million )
  14. Asia-Pacific Blood Banks Market By Region, From 2019-2024 ( USD Million )
  15. Asia-Pacific Home Care Settings Market By Region, From 2019-2024 ( USD Million )
  16. Asia-Pacific Other End Users Market By Region, From 2019-2024 ( USD Million )
  17. Japan HIV Diagnostics Market By Product, From 2019-2024 ( USD Million )
  18. Japan HIV Diagnostics Market By Type, From 2019-2024 ( USD Million )
  19. Japan HIV Diagnostics Market By End-User, From 2019-2024 ( USD Million )
  20. China HIV Diagnostics Market By Product, From 2019-2024 ( USD Million )
  21. China HIV Diagnostics Market By Type, From 2019-2024 ( USD Million )
  22. China HIV Diagnostics Market By End-User, From 2019-2024 ( USD Million )
  23. India HIV Diagnostics Market By Product, From 2019-2024 ( USD Million )
  24. India HIV Diagnostics Market By Type, From 2019-2024 ( USD Million )
  25. India HIV Diagnostics Market By End-User, From 2019-2024 ( USD Million )
  26. Australia HIV Diagnostics Market By Product, From 2019-2024 ( USD Million )
  27. Australia HIV Diagnostics Market By Type, From 2019-2024 ( USD Million )
  28. Australia HIV Diagnostics Market By End-User, From 2019-2024 ( USD Million )
  29. South Korea HIV Diagnostics Market By Product, From 2019-2024 ( USD Million )
  30. South Korea HIV Diagnostics Market By Type, From 2019-2024 ( USD Million )
  31. South Korea HIV Diagnostics Market By End-User, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample